CMTM6 Stabilizes PD‐L1 Expression and Is a New Prognostic Impact Factor in Hepatocellular Carcinoma

CKLF‐like MARVEL transmembrane domain containing 6 (CMTM6) was identified as a regulator of programmed death ligand 1 (PD‐L1), which induces antitumor immunity in several cancers. This study aimed to clarify the relationship between CMTM6 and PD‐L1 expression and clinical outcomes in patients with h...

Descripción completa

Detalles Bibliográficos
Autores principales: Yugawa, Kyohei, Itoh, Shinji, Yoshizumi, Tomoharu, Iseda, Norifumi, Tomiyama, Takahiro, Morinaga, Akinari, Toshima, Takeo, Harada, Noboru, Kohashi, Kenichi, Oda, Yoshinao, Mori, Masaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850307/
https://www.ncbi.nlm.nih.gov/pubmed/33553979
http://dx.doi.org/10.1002/hep4.1643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850307/
https://www.ncbi.nlm.nih.gov/pubmed/33553979
http://dx.doi.org/10.1002/hep4.1643

Ejemplares similares